This terminology is a snapshot as of 2026‑02‑11 10:48:51. Terminologies may evolve
over time. If you need recent (dynamic) versions of this terminology, please retrieve
it from the source.
RNA, (Am-sp-(2′-deoxy-2′-fluoro)C-sp-Am-Um-Am-(2′-deoxy-2′-fluoro)A-Gm-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)C-Am-Um-Um-Am-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)C-Um-Am-Am-Um-Gm-sp-Gm-sp-Gm),
complex with RNA (Cm-sp-Am-sp-Um-Um-Am-Gm-(2′-deoxy-2′-fluoro)G-Am-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)A-Um-Gm-Um-Cm-Um-Um-Am-Um-Gm-Um)
3′-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl
hydrogen phosphate] (1:1)
2.16.840.1.113883.3.6905.2
0‑L
300000013627
(2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic
acid, octasodium salt
3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-,
inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6-diazahexadec-1-yl]-44-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,8,26,42-tetraoxo-2,13,16,19,22,29,32,35,38-nonaoxa-5,9,25,41-tetraazatetratetracont-1-yl]-2-[(2-bromo-2-methyl-1-oxopropoxy)methyl]-1,3-propanediyl]
bis(2-bromo-2-methylpropanoate)
L-methionylglycyl-L-seryl-L-serylhexa-L-histidyl-L-seryl-L-serylglycyl-L-leucyl-L-valyl-L-prolyl-larginylglycyl-L-seryl-L-histidyl-L-methionyl-L-alanyl-L-seryl-L-methionyl-L-threonylglycylglycyll-glutaminyl-L-glutaminyl-L-methionylglycyl-L-arginyl-L-aspartyl-L-prolyl-des-(1-25)-cysteineproteinase
EP-B 2 precursor (Hordeum vulgare) fusion protein with l-asparaginyl-tri-lseryl-L-valyl-L-aspartyl-L-lysyl-L-leucyl-tri-L-alanyl-L-leucyl-L-glutamylhexa-L-histidine
S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cysteinylglycyl-L-serinylglycylgylcyl-L-isoleucyl-L-lysyl-L-glutamyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-histyl-L-isoleucyl-L-valyl-L-glutaminyl-L-serinyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-threonyl-L-serinamide,
acetate salt
2.16.840.1.113883.3.6905.2
0‑L
300000040910
(2S,3R)-2-[[(3S)-4-amino-3-(3-chlorophenyl)butanoyl]amino]-N-[(2S)-3-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]-3-hydroxybutanamide
acetic acid salt
2.16.840.1.113883.3.6905.2
0‑L
300000014560
Adalimumab conjugated with (4S)-4-[2-(2-bromoacetamido)acetamido]-5-{3-[(4-{(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-4a,6a-dimethyl-2-oxo-6b-[(phosphonooxy)acetyl]-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8-yl}phenyl)methyl]
anilino}-5-oxopentanoic acid
2.16.840.1.113883.3.6905.2
0‑L
100000142686
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY FOUR-TIME POTENTIATION
WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS AND SUBSEQUENT
POTENTIATION WITH SUGAR SYRUP PRODUCED THERE FROM)(HAB, SV5B)
Humanised IgG1 monoclonal antibody against HER2 conjugated to (2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide
Preparation of Symphytum x uplandicum herb (DER 0.2-0.9:1), composed of 40 % liquid
extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid
extract from the press residue after aqueous extraction of Symphytum x uplandicum
herb, extraction solvent: ethanol 30 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000050922
Preparation of Symphytum x uplandicum herb (DER 0.5-0.7:1), composed of 40 % liquid
extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid
extract from the press residue after aqueous extraction of Symphytum x uplandicum
herb, extraction solvent: ethanol 30 % (V/V)
N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine,
acetate salt
ADENOVIRAL VECTOR OF SEROTYPE 5 MODIFIED TO CONTAIN A CHIMERIC SEQUENCE CONSISTING
OF A MINIMAL UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR PROMOTER PRECEDED BY THREE
NOTCH-RESPONSIVE ELEMENTS, AND COATED WITH OLIGOPEPTIDE END-MODIFIED POLY (BETA-AMINO)
ESTERS
2.16.840.1.113883.3.6905.2
0‑L
300000034815
L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-methionyl-L-prolyl-L-phenylalanyl-L-alanyl-L-threonyl-L-prolyl-L-methionyl-L-glutamyl-L-alanyl-L-glutamyl-L-leucyl-L-alanyl-L-arginyl-L-arginyl-L-seryl-L-leucyl-L-alanine
acetate salt
2.16.840.1.113883.3.6905.2
0‑L
100000183759
REFINED AND QUANTIFIED DRY EXTRACT OF GINKGO BILOBA DRIED LEAF (35-67:1), CORRESPONDING
TO 13,2–16,2 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1,68–2,04 MG OF GINKGOLIDES
A, B AND C, 1,56–1,92 MG OF BILOBALIDE, EXTRACTION SOLVENT: ETHANOL 59-65% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
100000145401
PREPARATION OF FRESH HERB OF SYMPHYTUM X UPLANDICUM (40% OF PRESSED JUICE OF FRESH
HERB OF SYMPHYTUM X UPLANDICUM, DER 3-8:1, AND 60% OF AN EXTRACT OF THE PRESS RESIDUE
FROM FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-10:1, EXTRACTION MEDIUM ETHANOL 30%
V/V)
5-[4-[(2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]-5-oxopentanoic
acid radioallebled with gallium-68
2.16.840.1.113883.3.6905.2
0‑L
300000008772
Refined and quantified dry extract of ginkgo biloba dried leaf (35-67:1), corresponding
to 52,8–64,8 mg of flavonoids expressed as flavone glycosides, 6,72–8,16 mg of ginkgolides
a, b and c, 6,24–7,68 mg of bilobalide, extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000004101
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of the
mutated DnaE intein from Synechocystis sp. fused to the CEP290 body of the gene coding
sequence and fused to the 5'-coding sequence of DnaB intein from Rhodothermus marinus
2.16.840.1.113883.3.6905.2
0‑L
300000015285
Refined and quantified dry extract of ginkgo biloba leaves (35-67:1) quantified to
22.0 to 27.0 % of flavonoids expressed as flavone glycosides, 2.8 to 3.4 % of ginkgolides
a, b and c, and 2.6 to 3.2 % of bilobalide. extraction solvent: acetone 60% (m/m)
2.16.840.1.113883.3.6905.2
0‑L
300000042900
Clostridium botulinum A, strain CBAM0804 Hall-A, nontoxic-nonhaemagglutinin subunit
fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin
3b fused to haemagglutinin 1 fused to haemagglutinin 3a fused to haemagglutinin 2
2.16.840.1.113883.3.6905.2
0‑L
300000040031
Preparation of Symphytum officinale herb (DER 0.2 – 0.9 : 1), composed of 0.4 g of
pressed juice from dried Symphytum officinale herb and 0.6 g of extract from the press
residue of dried Symphytum officinale herb, Extraction solvent: ethanol 30% (V/V)
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM
QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY 5 MALIGE EXPONENTIATION
WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS) (HAB, SV5B)
2.16.840.1.113883.3.6905.2
0‑L
300000011940
Refined and quantified dry extract from ginkgo leaf (35-67:1), 80 mg corresponding
to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,2-2,7 mg of ginkgolides
A, B and C, 2,1-2,6 mg of bilobalide, extraction solvent: acetone 60% (M/M)
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 17,6–21,6
mg of flavonoids expressed as flavone glycosides, 2,24–2,72 mg of ginkgolides A, B
and C, 2,08–2,56 mg of bilobalide, Extraction solvent: ethanol 59-65% (V/V)
Extract of lysates from Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus
sanguinis, Streptococcus pyogenes, Klebsiella pneumoniae ssp. pneumoniae, Klebsiella
pneumoniae ssp. ozaenae, Staphylococcus aureus and Moraxella catarrhalis
2.16.840.1.113883.3.6905.2
0‑L
300000034960
Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 26,4–32,4
mg of flavonoids expressed as flavone glycosides, 3,36–4,08 mg of ginkgolides A, B
and C, 3,12–3,84 mg of bilobalide, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000142693
QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO DIL. D12 AQUOS. (HAB, SV5B: SOLN=D6
PRODUCED BY 5 MALIGE POTENTIATION OF QUERCUS ROBUR/PETRAEAE CORTICE, DECOCTUM Ø (HAB
VS.23A) WITH SATURATED AQUEOUS SOLUTION OF CALCAREAE CINERE QUERCUS)
2.16.840.1.113883.3.6905.2
0‑L
300000037378
Refined and quantified dry extract from ginkgo leaf (35-67:1), quantified to 17,6-21,6
mg of flavonoids expressed as flavone glycosides, 2,08-2,56 mg of bilobalide, 2,24-2,72
mg of ginkgolides a, b and c, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000039140
Refined and quantified dry extract from Ginkgo leaf (35-67:1), corresponding to 23.1-
28.4 mg of flavonoids expressed as flavone glycosides, 2.9-3.6 mg of ginkgolides A,
B and C, 2.7-3.4 mg of bilobalide, Extraction solvent: acetone 60% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000168633
GINKGO DRY EXTRACT (35-67:1), REFINED AND QUANTIFIED 80 MG CORRESPONDING TO: 17,6-21,6
MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 2,2-2,7 MG OF GINKGOLIDES A, B AND
C, 2,1-2,6 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 65% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000056177
Soft extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1),
DER genuine 12-28: 1, First extraction solvent: water, acetone, sodium laurilsulfate
(27:1:0.01 w/w/w), Second extraction solvent: acetone (100%)
VACCINIA VIRUS STRAIN ANKARA-BAVARIAN NORDIC-BRACHYURY CO-EXPRESSING THE BRACHYURY
HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3,
THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
Refined and quantified Ginkgo dry extract (35-67:1), corresponding to 8.80-10.80 mg
of flavonoids expressed as flavone glycosides, 1.12-1.36 mg of ginkgolides A, B and
C, 1.04-1.28 mg of bilobalide, extraction solvent: acetone 60% M/M
Humanised IgG1 monoclonal antibody against BCMA conjugated to 20-methyl-1-(3-methyl-3,9-dihydro-8H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-8-yl)-1,5,21-
trioxo-8,11,14,17-tetraoxa-4,20-diazapentacosan-25-oyl desacetyl maytansinoid
2.16.840.1.113883.3.6905.2
0‑L
300000042919
Clostridium botulinum A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy
chain fused to neurotoxin light chain fused to haemagglutinin 50 fused to haemagglutinin
33 fused to haemagglutinin 20 fused to haemagglutinin 17
SOFT EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS
(30:1.5:1), DER: 12–28:1, FIRST EXTRACTION SOLVENT: WATER: ACETONE : SODIUM LAURILSULFATE
(96:4:0.022 M/M/M), SECOND EXTRACTION SOLVENT: ACETONE
2.16.840.1.113883.3.6905.2
0‑L
100000145019
AQUEOS EXTRACT (1:15,6) FROM 2,5 G FROM A MIXTURE OF HAWTHORN LEAF AND FLOWER, VALERIAN
ROOT, MELISSA LEAF, MISTLETOE, HOPS STROBILE, ROSEMARY LEAF, BITTER ORANGE PEEL, LAVENDER
FLOWER (7:4:4:3:2:2:2:1), EXTRACTION LIQUID: WATER
EXTRACTUM SICCUM COMPOSITUM (4- 9 : 1) EX BAPTISIAE TINCTORIAE L. RADIX 4,92 P., ECHINACEAE
PURPUREAE (L.) MOENCH RADIX 1,85 P., ECHINACEAE PALLIDAE NUTT. RADIX 1,85 P., THUJAE
OCCIDENTALIS L. HERBA 1 P., ETHANOL 30 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000045868
Dry extract refined from Birch bark, equivalent to 0.5-1.0 g birch bark, including
84-95 mg triterpenes calculated as the sum of betulin, betulinic acid, erythrodiol,
lupeol and oleanolic acid, Extraction solvent: n-heptane
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral
vector encoding a chimeric antigen receptor targeting human claudin 18.2 antigen with
CD28 and CD3-zeta intracellular signalling domains
LIQUID EXTRACT FROM ONOPORDUM ACANTHIUM FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99
PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB
[(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
LIQUID EXTRACT FROM A MIXTURE (4.7:1) OF MATRICARIA CAPITULA AND RAY FLORETS (DER
1:4.0-4.5), EXTRACTION SOLVENTS: ETHANOL 96% (V/V), PURIFIED WATER, SODIUM ACETATE
TRIHYDRATE, SODIUM ASCORBATE AND SODIUM HYDROXIDE
Refined and quantified dry extract from Vaccinium macrocarpon fruit juice (20-35:1),
corresponding to 36 mg (34.2-37.8 mg) of proanthocyanidins expressed as proanthocyanidins
A2, extraction solvent: ethanol 70% V/V
EXTRACT (1:12.4) OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE,
HOP STROBILE, ROSEMARY LEAF, BITTER-ORANGE EPICARP AND MESOCARP, LAVENDER FLOWER (7:4:4:3:2:2:2:1),
EXTRACTION SOLVENT: WATER
2.16.840.1.113883.3.6905.2
0‑L
100000183100
FOWLPOX VIRUS STRAIN TBC-FPV CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN,
THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION
MOLECULE 1 AND THE HUMAN CD80 ANTIGEN
LIQUID EXTRACT FROM PRIMULA VERIS FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS
OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER
1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)]
Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes
and transduced with a lentiviral vector to express two chimeric antigen receptors
independently directed against CD20 and CD22
Adeno-associated viral vector serotype 8 encoding B-domain deleted liver specific
codon optimized bioengineered chimeric human porcine factor VIII, under a synthetic
hepatic combinatorial bundle promoter
2.16.840.1.113883.3.6905.2
0‑L
300000043585
Dry standardised extract from milk thistle fruit equivalent to 3325 mg – 9720 mg of
milk thistle fruit corresponding to 108 mg of silymarin calculated as silibin, Extraction
solvent: acetone 99.9 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000056648
Liquid extract (1:11) from Marshmallow root, Chamomile flower, roman, Equisetum stem,
Juglans regia leaf, Yarrow, Oak bark, Dandelion herb with root (4:3:5:4:4:2:4), Extraction
solvent: ethanol 59% (V/V)
Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes
and transduced with lentiviral vector expressing a chimeric antigen receptor against
CD22 and RQR8 depletion mechanism
2.16.840.1.113883.3.6905.2
0‑L
300000032498
Hop strobile oleoresin, corresponding to 3.36 g potassium hop beta acids, expressed
as potassium lupulone, potassium adlupulone and potassium colupulone, Extraction solvent:
supercritical carbon dioxide
2.16.840.1.113883.3.6905.2
0‑L
300000003598
Dry extract from rhubarb root (30-70 parts) and rheum australe root (30-70 parts),
corresponding to 4.3-5.3 mg of hydroxyanthracene derivatives, calculated as rhine,
extraction solvent: ethanol 90% V/V
3-(3-carboxypropyl)-2-[2-[3-[2-[1,3-dihydro-3,3-dimethyl-1-(3-sulfopropyl)-2H-indol-2-ylidene]ethylidene]-2-(4-sulfophenoxy)-1-cyclohexen-1-yl]ethenyl]-3-methyl-1-(3-sulfopropyl)-3H-indolium
inner salt
Turkey herpesvirus, strain HVT/IBD/ILT (cell-associated), expressing VP2 protein gene
of Infectious bursal disease virus and gD and gI glycoproteins genes of Infectious
laryngotracheitis virus, Live
LIQUID EXTRACT OF ICELAND MOSS, SAPONARIA OFFICINALIS ROOT, PIMPINELLA ROOT, EUCALYPTUS
LEAF, FENNEL BITTER FRUIT (1:1:1:1:1) AND 1 PART OF STAR ANISE (1:3-4), EXTRACTION
SOLVENT: ETHANOL 30% V/V
2.16.840.1.113883.3.6905.2
0‑L
100000176534
LIQUID EXTRACT (0,65:1) FROM A MIXTURE OF: MATRICARIA FLOWER, OAK BARK, SAGE LEAF,
ARNICA HERB, CALAMUS RHIZOME, PEPPERMINT HERB, THYME HERB (2:2:2:1:1:1:1), EXTRACTION
SOLVENT: ETHANOL 70% (V/V)
Dry extract from tinnevelly senna pods and alexandrian senna pods (4.5-5.5:1), 100-166.5
mg corresponding to 10 mg hydroxyanthracene glycosides, calculated as sennoside B,
extraction agent: water
2.16.840.1.113883.3.6905.2
0‑L
300000027651
Allogeneic bone marrow-derived haematopoietic stem and progenitor cells treated ex
vivo with the protein transduction domain of the HIV-1 transactivation protein fused
to MYC transcription factor
2.16.840.1.113883.3.6905.2
0‑L
300000027671
Autologous bone marrow-derived haematopoietic stem and progenitor cells treated ex
vivo with the protein transduction domain of the HIV-1 transactivation protein fused
to MYC transcription factor
Autologous peripheral blood-derived CD4 and CD8 T lymphocytes, transduced with a lentiviral
vector to expressing a chimeric receptor against BCMA with co-stimulatory sequences
4-1-BB and CD3 zeta
Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein
gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis
virus, Live
Dry extract from milk thistle fruit, (equivalent to 3.725 g – 10.818 g of milk thistle
fruits) corresponding to 108 mg of silymarin, calculated as silibinin. extraction
solvent: acetone 95% v/v
Polypeptide consisting of a glucagon-like peptide-1 receptor agonist and an amylin
receptor agonist, connected by a linker with 4 glycine residues, and connected to
a C18 fatty acid side chain
Dry extract of Ginkgo leaf (40-50:1), corresponding to 17.6-21.6 mg of flavone glycosides,
2.2-2.7 mg of ginkgolides A, B and C, 2.1-2.6 mg of bilobalide, Extraction solvent:
ethanol 50% (V/V)
Human donor haematopoietic stem and progenitor cells that have been treated ex vivo
with the protein transduction domain of the HIV-1 transactivation protein fused to
MYC transcription factor
2.16.840.1.113883.3.6905.2
0‑L
300000037858
Liquid extract from fresh Purple coneflower root corresponding to 15-21 mg of fresh
purple solhatt root, equivalent to 4 mg of dried purple solhatt root, Extraction solvent:
ethanol 57.3% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000039488
Liquid extract from a mixture (2.5: 2.5: 1) of thyme, wild thyme, Ribwort plantain
(DER 1:2.9-3.3), Extraction solvent: glycerol 85% M/M, ethanol 96% V/V and purified
water (1:7.5:31.2 m/m/m)
Plasmid DNA which encoding a human IgG1 antibody molecule containing a epitope derived
from the TRP-2 melanoma antigen plus two helper T-cell sequences derived from the
melanoma gp100 protein
Dry extract from milk thistle fruit (equivalent to 1.721 g – 5.000 g of milk thistle
fruits) corresponding to 50 mg of silymarin, calculated as silibinin. Extraction solvent,
acetone 95% v/v
Dry extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1),
DER genuine 2.7-7.5:1, Extraction solvents: water, acetone, sodium laurilsulfate (27:1:0.01
w/w/w)
2.16.840.1.113883.3.6905.2
0‑L
100000170412
DRY EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS
(30:1.5:1), DER: 2.7-7.5:1, EXTRACTION SOLVENT: WATER : ACETONE : SODIUM LAURILSULFATE
(96:4:0.022 M/M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000011554
Dry standardised extract from milk thistle fruit equivalent to 8100 g of milk thistle
fruit corresponding to 174 mg of silymarin calculated as silibin, extraction solvent:
acetone 95% (V/V)
Autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor
cells transduced ex vivo using a replication-incompetent lentiviral vector encoding
the NOD2 gene
2.16.840.1.113883.3.6905.2
0‑L
300000018872
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, New-Jersey
serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax,
HBZ, p12I and p30II
LIQUID EXTRACT FROM A MIXTURE OF PLANTAGO LANCEOLATA LEAF AND MALVA SYLVESTRIS FLOWER,
CORRESPONDING TO 0.25 G OF LANCEOLATE LEAF AND 0.25 G OF SALIVA FLOWER, EXTRACTION
SOLVENT: WATER
Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, Indiana serotype,
encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I
and p30II
2.16.840.1.113883.3.6905.2
0‑L
300000037838
Liquid extract from fresh Purple coneflower herb corresponding to 222-406 mg of fresh
purple solhatt, equivalent to 72 mg of dried purple solhatt. Extraction solvent: ethanol
57.3% M/M
Dry extract of Horse-chestnut equivalent to 1.08 - 1.60 g of Horse-chestnut corresponding
to 50 mg of triterpene glycosides calculated as aescin, extraction solvent: ethanol
50% (v/v)
EXTRACT (1:11) OF GENTIAN ROOT CUT, VERBENA HERB CUT, COMMON SORREL HERB CUT, ELDER
FLOWER RUBBED, PRIMULA FLOWER WITH CALYX CUT: (1:3:3:3:3), EXTRACTION SOLVENT: ETHANOL,
59% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000004100
Adeno-associated viral vector serotype 8 containing the 5'-fragment of CEP290 gene
coding sequence fused to the 5'-coding sequence of the mutated DnaE intein from Nostoc
punctiforme
DRY EXTRACT FROM MILK THISTLE (36-44:1) CORRESPONDING TO 108 MG OF SILYMARIN (HPLC)
OR 140 MG SILYMARIN (DNPH), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
98% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000037401
Standardised dry extract from Cascara sagrada (DER 4-6:1), equivalent to 15 mg of
hydroxyanthracene heterosides, expressed as cascarosides a, Extraction solvent: ethanol
60% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000044704
DNA plasmid encoding the human IgG3 monoclonal antibody hinge and CH3, influenza A/Shanghai/2/2017
(H7N9) hemagglutinin and a single-chain variable fragment specific against HLAII
2.16.840.1.113883.3.6905.2
0‑L
300000049402
Turkey herpesvirus, strain rHVT/ND/H9 (cell-associated), expressing fusion protein
gene of Newcastle disease virus and hemagglutinin gene of Avian influenza virus subtype
H9, Live
2.16.840.1.113883.3.6905.2
0‑L
300000050332
Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein
gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype
H5, Live
Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope
glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein
2.16.840.1.113883.3.6905.2
0‑L
100000183263
Allogeneic pancreatic cancer cells derived from panc 10.05 tumor cell line transfected
with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor
gene
2.16.840.1.113883.3.6905.2
0‑L
300000028153
Dry extract from Ginkgo (35-67:1), refined and quantified corresponding to 22 - 27%
flavonoids, 2.6 - 3.2% bilobalide, 2.8 - 3.4% ginkgolides, Extraction solvents: acetone,
water
2.16.840.1.113883.3.6905.2
0‑L
300000041674
Fusion protein containing a humanised Llama single domain antibody against PSMA, a
humanised Llama single domain antibody against HAS and a humanised single chain Fv
against CD3e
2.16.840.1.113883.3.6905.2
0‑L
100000183262
Allogeneic pancreatic cancer cells derived from panc 6.03 tumor cell line transfected
with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor
gene
2.16.840.1.113883.3.6905.2
0‑L
300000032853
Liquid extract (1:5) from Melissa leaf, Hawthorn leaf and flower, Matricaria flower,
Angelica archangelica root, Caraway fruit (8:7:2:2:1), extraction solvent: ethanol
40% (V/V)
Autologous CD34+ enriched population containing haematopoietic stem and progenitor
cells transduced ex vivo with a lentiviral vector encoding the human programmed death-ligand
1
2.16.840.1.113883.3.6905.2
0‑L
300000054707
Turkey herpesvirus, strain rHVT/ND/IBD (cell-associated), expressing fusion protein
gene of Newcastle disease virus and VP2 protein gene of Infectious bursal disease
virus, Live
2.16.840.1.113883.3.6905.2
0‑L
100000159896
EXTRACT (1:38.5) FROM GENTIAN ROOT, VERBENA HERB, COMMON SORREL HERB, ELDER FLOWER,
PRIMULA FLOWER WITH CALYX (1:3:3:3:3), EXTRACTING AGENTS: ETHANOL 59 % (V/V), PURIFIED
WATER
Turkey herpesvirus, strain HVT-IBD-ND (cell-associated), expressing VP2 protein gene
of Infectious bursal disease virus and fusion protein gene of Newcastle disease virus,
Live
REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (24-27: 1) CORRESPONDING
TO 77.76 - 95.04 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ACETONE
95 %
2.16.840.1.113883.3.6905.2
0‑L
300000016580
Mycobacterium bovis, strain Bacillus Calmette-Guérin, subtype Prague, containing listeriolysin
encoding gene from Listeria monocytogenes in the place of urease C encoding gene
2.16.840.1.113883.3.6905.2
0‑L
300000033908
Refined and quantified dry extract from ginkgo leaf (35-45: 1), corresponding to 15
mg of flavone glycosides and 3.5 mg of terpenlactone, Extraction solvent: acetone
60% (M/M)
OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254
MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM
HYDROXIDE
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000090163
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000090164
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163404
HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163405
HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163406
HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163407
HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000163408
HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000178075
LIQUID EXTRACT FROM A MIXTURE OF SOLANUM DULCAMARA STEM, MARRUBIUM VULGARE LEAF, ANISEED,
WILD THYME AND THYME (1:2.33:3.33:2.33:19) (DER: 1: 6-7), EXTRACTION SOLVENT: WATER
Natural killer cell engager composed of a single-chain variable fragment against hepatocyte
growth factor receptor, a Fab arm against NKG2D, and an Fc fragment against CD16a
2.16.840.1.113883.3.6905.2
0‑L
100000090165
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES
PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA
2.16.840.1.113883.3.6905.2
0‑L
100000130744
DRY EXTRACT FROM MILK THISTLE FRUIT (DER 36-44:1) EQUIVALENT TO 75.0-80.9% SILYMARIN
(DNPH) AND 58.0-62.5% (HPLC), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
2.16.840.1.113883.3.6905.2
0‑L
100000169936
Turkey herpesvirus, strain HVP360 (cell-associated), expressing fusion protein gene
of Newcastle disease virus and VP2 protein gene of Infectious bursal disease virus,
Live
Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of DnaB
intein from Rhodothermus marinus fused to the 3'-fragment of CEP290 gene coding sequence
Human T lymphoid progenitor cells obtained after a brief period of ex vivo culture
in the presence of the fusion protein DL-4, retronectin and a combination of cytokines
Human Papillomavirus type 16 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide,
hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
2.16.840.1.113883.3.6905.2
0‑L
300000020672
Human Papillomavirus type 18 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide,
hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived
DRY EXTRACT OF HORSE CHESTNUT, STANDARDISED (DER 5-7:1), ADJUSTED TO 30 MG OF TRITERPENE
GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: ETHANOL 50 % (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000179994
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-CYSTEINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
300000017300
Soft extract from purple coneflower, corresponding to 300-600 mg purple coneflower
herb and to 17-29 mg purple coneflower root, extraction solvent: ethanol 57.3 % (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000020691
Mixture of allergen extracts from Alnus spp., Fraxinus spp., Fagus spp., Betula spp.,
Ulmus spp., Corylus spp., Quercus spp., Planatus spp., Populus spp. and Salix spp.
2.16.840.1.113883.3.6905.2
0‑L
300000040250
Clostridium botulinum A, strain PM-12759 Hall-A, botulin A conjugated to protein NTNH,
hemagglutinin HA17, hemagglutinin HA34, hemagglutinin HA23 and hemagglutinin HA48
2.16.840.1.113883.3.6905.2
0‑L
100000173488
EXTRACT (0,218:1) OF BITTER ORANGE PEEL, CONDURANGO, CLOVE, GINGER, CINNAMON AND ANGELICA
ARCHANGELICA ROOT (625:10:9:5:2,5:1), EXTRACTION SOLVENT: ETHANOL 70% (V / V)
2.16.840.1.113883.3.6905.2
0‑L
100000174320
DRY EXTRACT (4.2-5.6:1) OF CASCARA 57-108 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE
DERIVATIVES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 52% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000179995
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ASPARTYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000179999
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-GLYCYL-L-ASPARTYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000183784
Adeno-associated viral vector serotype 8 containing the 5'-half region of CEP290 gene
coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
2.16.840.1.113883.3.6905.2
0‑L
300000037206
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding
to 22.5 mg silymarin, calculated as silibinin, Extraction solvent: methanol 98% (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000039345
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding
to 70 mg of silymarin, calculated as silibinin, Extraction solvent: acetone 95% (V/V)
Refined and standardized dry extract of Milk Thistle fruit (24-27:1), corresponding
to 4.06 mg of silymarin expressed as silibinin. Extraction solvent: acetone 95% v/v
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic
acid conjugated to bombesin and radiolabeled with technetium-99m
LIQUID EXTRACT (1:1.0-1.2) OF CASCARA 500 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE
GLYCOSIDES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 30% M/M
2.16.840.1.113883.3.6905.2
0‑L
100000179996
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ARGINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000183279
Adeno-associated viral vector serotype 8 containing the 5'-half region of ABCA4 gene
coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein
2.16.840.1.113883.3.6905.2
0‑L
300000016600
Mixture of allergen extracts of Phleum pratense, Dactylis glomerata, Poa pratensis,
Holcus lanatus, Festuca elatior and Lolium perenne polymerized with glutaraldehyde
2.16.840.1.113883.3.6905.2
0‑L
300000032682
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with
the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene
2.16.840.1.113883.3.6905.2
0‑L
300000033927
Autologous CD34+ cell enriched population containing haematopoietic stem and progenitor
cells transduced ex vivo with a lentiviral vector encoding the human ADA2 gene
MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED 123,0 - 208,3 MG CORRESPONDING
TO 83,3 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE
2.16.840.1.113883.3.6905.2
0‑L
100000179993
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ALANYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000184187
Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically
corrected by CRISPR/Cas9-mediated excision of mutation-carrying COL7A1 exon 80
2.16.840.1.113883.3.6905.2
0‑L
300000026364
Standardised dry extract of frangula bark (DER 5-7: 1) corresponding to 15 mg of glucofrangulins
expressed as glucofrangulin A, extraction solvent: ethanol 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000037257
Dry extract from Hippophae rhamnoides, refined and standardised (DER 35-50:1), corresponding
to 110 mg silymarin, calculated as silibin, Extraction solvent: methanol
2.16.840.1.113883.3.6905.2
0‑L
300000041564
Refined and quantified dry extract of ginkgo leaf (35-67:1), quantified to 24% of
ginkgo glycosides, 6% ginkgolides-bilobalide, Extraction solvent: acetone 60% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
300000046508
Refined and quantified dry extract from Ginkgo leaf, corresponding to 9.6 mg of glycosides
and 2.4 mg ginkgolides and bilobalide, Extraction solvent: acetone 60% M/M
(14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic
acid conjugated to bombesin and radiolabeled with lutetium-177
2.16.840.1.113883.3.6905.2
0‑L
100000179997
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-SERYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
100000179998
L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-VALYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE,
HYDROCHLORIDE SALT
2.16.840.1.113883.3.6905.2
0‑L
300000011402
Dry extract from tribulus terrestris herba (35-45:1), corresponding to 125 mg furostanol
saponins calculated as protodioscin, extraction solvent: methanol 80% (V/V)
MILK THISTLE FRUIT DRY EXTRACT, REFINED AND STANDARDISED (22-27:1) CORRESPONDING TO
200 MG OF SYLIMARIN, CALCULATED AS SYLIBIN, EXTRACTION SOLVENT: ACETONE 95% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000013240
Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding
to 140 mg silymarin, calculated as silibinin, extraction solvent: acetone 95% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000018300
Pneumococcal polysaccharide serotype 23F conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Autologous T-cells expressing an antibody coupled T-cell receptor composed of CD16
extracellular domain, CD3zeta-signaling domain and a 4-1BB co-stimulatory domain
2.16.840.1.113883.3.6905.2
0‑L
300000051582
Extract of Phoradendron leucarpum herb (1:50), Extraction solvent: sodium monohydrogen
phosphate dihydrate, ascorbic acid and water for injection (2.03:0.34:97.63)
Pneumococcal polysaccharide serotype 6B conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018295
Pneumococcal polysaccharide serotype 7F conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018296
Pneumococcal polysaccharide serotype 9V conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018297
Pneumococcal polysaccharide serotype 14 conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000034979
Autologous haematopoietic stem and progenitor cell population containing CD34+ cells
transduced with a lentiviral vector encoding the TCIRG1 cDNA ex vivo expanded
2.16.840.1.113883.3.6905.2
0‑L
300000038478
Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated
virus vector serotype 6 containing the codon-optimized version of PKLR gene
2.16.840.1.113883.3.6905.2
0‑L
300000043943
(2R,4E)-7-chloro-4-(2-oxo-1-phenyl-pyrrolidin-3-ylidene)-1,2,3,4-tetrahydroquinoline-2-carboxylic
acid, (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentanol salt
AQUEOUS EXTRACT FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER,
0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
Dry extract from horse chestnut seed (4.5-5.5:1) corresponding to 50 mg triterpene
glycosides calculated as anhydrous aescin, extraction solvent: ethanol 50% V/V
2.16.840.1.113883.3.6905.2
0‑L
300000018291
Pneumococcal polysaccharide serotype 1 conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018292
Pneumococcal polysaccharide serotype 4 conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
2.16.840.1.113883.3.6905.2
0‑L
300000018293
Pneumococcal polysaccharide serotype 5 conjugated to protein D (derived from non-typeable
Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate
Adeno-associated viral vector serotype 8 containing a functional copy of the codon-optimised
F8 cDNA encoding the B-domain deleted human coagulation factor VIII
Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with
a lentiviral vector encoding for the N-acetylgalactosamine 6-sulfatase cDNA
Leu-Asn-Ser-Lys-Ile-Ala-Phe-Lys-Ile-Val-Ser-Gln-Glu-Pro-Ala conjugated to an iron
oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047775
Thr-Pro-Met-Phe-Leu-Leu-Ser-Arg-Asn-Thr-Gly-Glu-Val-Arg-Thr conjugated to an iron
oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047798
Arg-Glu-Gly-Ile-Ala-Phe-Arg-Pro-Ala-Ser-Lys-Thr-Phe-Thr-Val conjugated to an iron
oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000047799
Asn-Ile-Lys-Val-Lys-Asp-Val-Asn-Asp-Asn-Phe-Pro-Met-Phe-Arg conjugated to an iron
oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene)
2.16.840.1.113883.3.6905.2
0‑L
300000052153
Adeno-associated viral vector serotype 9 containing the human MECP2 gene, an intron
encoding a miRNA generating sequence, and complementary miRNA binding sites
2.16.840.1.113883.3.6905.2
0‑L
300000056041
Milk thistle dry extract, refined and standardised (22-27:1) of nominal content of
silymarin, expressed as silibinin 58%, Extraction solvent: 95% acetone (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000027279
Dry extract from senna pods and (DER 4.5-5.5:1), corresponding to 19.5 mg of hydroxyanthracene
glycosides, expressed as sennoside B, Extraction solvent: water
HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5)
FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide
mono methanesulfonic acid salt
2.16.840.1.113883.3.6905.2
0‑L
300000004140
Combination of three adeno-associated viral vectors of serotype 8 containing the 5'-,
the body- and the 3'- coding sequences of human CEP290 fused to inteins
Dry extract from Cucurbita pepo seeds deffatted (DER 5-10:1), extraction solvents:
sodium hydrogen carbonate, sodium chloride and purified water (3-6,1-90,9)
2.16.840.1.113883.3.6905.2
0‑L
300000027791
Dry extract from cranberry fruit juice, corresponding to 36 mg of proanthocyanidins,
calculated as proanthocyanidin A2, Extraction solvent: ethanol 70% (V/V)
Liquid extract from fresh purple coneflower root (DER 1:11), corresponding to 17-29
mg of fresh purple coneflower root, extraction solvent: ethanol 57.3% M/M
2.16.840.1.113883.3.6905.2
0‑L
300000051751
Salmonella typhi, strain Ty21a, Live encoding a fusion protein composed of prostate
specific antigen, cholera toxin B subunit and a secretion signal sequence
2.16.840.1.113883.3.6905.2
0‑L
300000054366
Allergenic extract of grass pollen mixture: Dactylis glomerata, Festuca pratensis,
Lolium perenne, Phleum pratense and Poa pratensis (1:1:1:1:1), polymerised
2.16.840.1.113883.3.6905.2
0‑L
100000143027
DISTILLATE FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095
G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS
2.16.840.1.113883.3.6905.2
0‑L
100000174280
DRY EXTRACT OF HORSE CHESTNUT SEEDS (5-8:1) ADJUSTED TO 50 MG OF TRITERPENE GLYCOSIDES
CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: METHANOL 80 % (V/V)
2.16.840.1.113883.3.6905.2
0‑L
300000015541
Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of
the viral antigens of Cytomegalovirus, Adenovirus and Epstein-Barr virus
Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding
to 110 mg silymarin, calculated as silibinin, Extraction solvent: methanol
Dry extract of Senna pods (5.6-6.8:1), adjusted to 12.5 mg of hydroxyanthracene glycosides,
expressed as sennoside B, Extraction solvent: methanol 80% (M/M)
2.16.840.1.113883.3.6905.2
0‑L
100000172436
MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR,
DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS, SECALE CEREALE
2.16.840.1.113883.3.6905.2
0‑L
300000009248
Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine,
phosphatidylserine, phospatidylinositol and cholesterol
2.16.840.1.113883.3.6905.2
0‑L
300000024774
Modified growth hormone releasing-hormone fused to the light chain endopeptidase and
the N-terminal domain of the heavy chain of botulinum toxin serotype D
2.16.840.1.113883.3.6905.2
This value set has 63646 codes in it. In order to keep the publication size manageable,
only a selection (500 codes) of the whole set of codes is shown.
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other)
suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute
instead of @code.